GSR United Capital
GSR United Capital, founded in 2009 and headquartered in Beijing, China, is a private equity and venture capital firm with additional offices in Hangzhou and Shenzhen. The firm specializes in equity investments within high-tech industries, targeting sectors such as artificial intelligence, robotics, advanced manufacturing, supply chain technology, the industrial internet, smart transportation, and environmental services. GSR United Capital actively seeks investment and merger and acquisition opportunities, particularly in projects at the "A+" stage, which are poised for scale commercialization. The firm manages both RMB master funds and industry-specific funds in partnership with local governments, receiving strong backing from various institutional investors, including government-guided funds and wealth management institutions. With a portfolio of over 100 high-tech startups, GSR United Capital has successfully exited several investments through public listings, achieving significant returns. The firm has continued to expand its investment activities, making over 30 investments since early 2020, and focuses on delivering substantial returns while fostering innovation in emerging technologies.
Xgene Pharmaceutical
Series C in 2021
Xgene Pharmaceutical Inc. is a late-clinical stage pharmaceutical company established in 2015, based in the Cayman Islands. It focuses on developing small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors. Utilizing proprietary linker technology, Xgene creates novel, multimodal conjugated molecules that enhance the efficacy and tolerability of pain medications. The company's current programs are dedicated to addressing unmet needs in neurological disorders, making significant strides in the development of innovative treatments for these conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.